Fondazione Sternberg Fondazione Sternberg
Efficacy and Safety of Darolutamide in Combination With ADT and Docetaxel by Disease Volume and Disease Risk in the Phase 3 ARASENS Study
Interviews

Efficacy and Safety of Darolutamide in Combination With ADT and Docetaxel by Disease Volume and Disease Risk in the Phase 3 ARASENS Study

Efficacy and Safety of Darolutamide in Combination With ADT and Docetaxel by Disease Volume and Disease Risk in the Phase 3 ARASENS Study

Cora N. Sternberg, is Full Professor of Medicine and the Clinical Director of the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, USA.


SAMUEL AND BARBARA STERNBERG ETS FOUNDATION

MORE ARTICLES

28 Nov
News

ASCO Daily News: Dr. Cora Sternberg article about prostate cancer

Is There Sufficient Evidence to Intensify Systemic Therapy in Patients With Prostate Cancer Who Have M1 by PSMA-PET but Negative Conventional Imaging?

Read more
06 Oct
Interviews

ESMO 2024: Cora Sternberg video interview

ESMO 2024: Cora Sternberg video interview about her presentation on event-free survival (EFS) as a surrogate endpoint for overall survival in muscle-invasive bladder cancer.

Read more
12 Sep
News

Investigation of novel pharmacological vulnerabilities of 9p21-deleted bladder cancer cells

This project received funding from the European Research Council (ERC) and from the Samuel and Barbara Sternberg Foundation.

Read more
13 Jul
Interviews

UroToday, Commentary by Cora Sternbeg

The INSIDE-PC study provides evidence of the potential of AI systems in medical literature searches on complex clinical questions.

Read more
12 Jul
Interviews

ESMO Congress 2024

ESMO Congress 2024 - European Society for Medical Oncology Barcellona 13-17 Settembre 2024

Read more
27 May
Interviews

Urothelial Carcinoma: New Developments

In this video Dr. Cora Sternberg discusses new developments in the treatment of urothelial carcinoma.

Read more
02 Jen
Interviews

AKT Inhibitors – Targeting PI3K/AKT/MTOR Signaling Axis - Cora Sternberg

In this interview for UroToday dr. Cora Sternberg presents the latest data and ongoing clinical trials in the context of prostate cancer.

Read more
04 Dec
Interviews

The EV-302 Study and the Implications for Metastatic Bladder Cancer Care

Alicia Morgans speaks with Cora Sternberg about the EV-302 study presented at ESMO 2023. This study marks a significant shift in treating advanced metastatic urothelial cancer, traditionally managed with cisplatin or carboplatin-based chemotherapy.

Read more
27 Oct
News

Exploration of therapeutic vulnerabilities exposed by 9p21 loss in bladder cancer cell lines.

Exploration of therapeutic vulnerabilities exposed by 9p21 loss in bladder cancer cell lines.

Read more
11 Oct
Congresses

SIU Congress 2023

Dr. Cora Sternberg lecture: Precision medicine for prostate cancer

Read more
05 Jul
News

Precision Medicine

Precision medicine is an emerging approach to the treatment and prevention of diseases that takes into account the individual variability of each person's genes, environment and lifestyle.

Read more
22 Jun
News

Projects

The Samuel and Barbara Research Foundation call for applications is open year long. Fellowships are available to those working in Italy in the field of Cancer research or related to cancer research.

Read more